Where does Spark Biomedical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Spark Biomedical, Inc. ranks #27,476 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Spark Biomedical, Inc. hold?

Spark Biomedical, Inc. holds 10 US utility patents granted between 2020 and 2025, spanning 3 technology areas.

What is Spark Biomedical, Inc.'s Innovation Score?

Spark Biomedical, Inc. has an Innovation Score of 40.3 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Spark Biomedical, Inc. focus on?

Spark Biomedical, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 10 patents, ranking #372 of 1,943 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Spark Biomedical, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Spark Biomedical, Inc..

What does claim depth mean for Spark Biomedical, Inc.'s patents?

Spark Biomedical, Inc.'s patents average 20.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Spark Biomedical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Spark Biomedical, Inc.

USPTO PatentsView assignee record - 10 granted patents across 3 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Spark ranks #27,476 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 3 technology areas.

#27,476
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.3/100): 20.9
avg claims per patent

USPTO PatentsView assignee plate

Corpus R27476 · US Corporation #27,476 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 10 grants
MID-PACK #27,476/49,997
PHOTO-FINISH Sonics & Materials
CPC-NARROW A61N · 3 areas
INNOV-PAR 40.3/100
CLAIMS-DENSE 20.9 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Sonics & Materials, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Spark’s 40.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (21%) Velocity 13.3 pts (33%) Breadth 6.1 pts (15%) Claim depth 12.5 pts (31%)

Qualcomm Incorporated · highest

85
Spark Biomedical · this assignee

40
3D Lighting… · lowest

7

What this shows Spark's Innovation Score is 40.3/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Spark?

Each dot is one of Spark’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Spark’s own 20.9 claims/patent is ABOVE the 13.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Spark vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Spark's grants concentrate

Spark Biomedical, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2024 (2 grants) versus a trough of 1 in 2020. By volume, Spark sits between Sonics & Materials, Inc. and Spellbound Development Group, Inc..

Spark's three-year grant acceleration

Spark Biomedical, Inc. shows 4 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Sonics & Materials

10
Sonnax Industries

10
Sony Network Comm…

10
Southwest Agri-pl…

10
Spartan Orthodont…

10
Specialty Mineral…

10
Spectralink

10
Spellbound Develo…

10
Spark Biomedical ◀

10

What this shows Spark holds 10 patents at rank #27,500, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Spark

By rank, the assignees closest to #27,500 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Spark's primary technology class.

Spark's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Spark Biomedical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	10.0%
2021	1	10.0%
2022	1	10.0%
2023	1	10.0%
2024	2	20.0%
2025partial year	4	40.0%

Which technologies does Spark Biomedical, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 10

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Spark Biomedical, Inc.'s patent record in context - here's where to go next.

Spark Biomedical, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #27,476 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Spark Biomedical, Inc. against Sonics & Materials, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.